Sanguedolce Francesca, Loizzi Domenico, Sollitto Francesco, Di Bisceglie Maurizio, Lucarelli Giuseppe, Carrieri Giuseppe, Bufo Pantaleo, Cormio Luigi
Department of Pathology, University Hospital, Foggia, Italy.
Oncology. 2017;92(3):125-134. doi: 10.1159/000454731. Epub 2017 Jan 6.
Lung cancer is the tumor with the highest incidence in males worldwide and the most common cause of death from cancer overall; its high mortality is mostly due to its propensity to spread to other organs through lymphatic and blood vessels in spite of proper treatment. Bladder metastases from lung cancer are rare, with only 11 cases having been reported, all in recent years. This review aims to discuss some critical points regarding this uncommon condition, namely: (a) lung and bladder tumors share similar etiologic features; (b) almost all bladder metastases from lung cancer arise from lung adenocarcinomas; (c) cytology and superficial bladder biopsy may be falsely negative, since the neoplastic cells coming through the hematogenous route are typically located in the lamina propria and/or muscularis propria of the bladder wall; and (d) the differential diagnosis with primary bladder adenocarcinoma as well as primary and secondary small-cell carcinomas may be challenging. Though no definite conclusions can be drawn regarding treatment, we herein propose a practical algorithm to manage such patients based on available data.
肺癌是全球男性中发病率最高的肿瘤,也是总体上癌症死亡的最常见原因;尽管进行了适当治疗,其高死亡率主要归因于它易于通过淋巴管和血管扩散到其他器官。肺癌的膀胱转移很少见,仅报告过11例,均为近年来的病例。本综述旨在讨论关于这种罕见情况的一些关键点,即:(a)肺癌和膀胱癌具有相似的病因特征;(b)几乎所有肺癌的膀胱转移都源于肺腺癌;(c)细胞学检查和浅表膀胱活检可能出现假阴性,因为通过血行途径转移的肿瘤细胞通常位于膀胱壁的固有层和/或肌层;以及(d)与原发性膀胱腺癌以及原发性和继发性小细胞癌的鉴别诊断可能具有挑战性。尽管关于治疗无法得出明确结论,但我们在此根据现有数据提出一种实用的算法来管理此类患者。